| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.05.24 | Cardurion Pharmaceuticals, Inc.: Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL-HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure | 984 | Business Wire | PDE9 inhibitor, CRD-740, demonstrated favorable safety profile and achieved statistical significance for the trial's primary endpoint, median increase in plasma cyclic guanosine monophosphate (cGMP)... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 3.620 |
| TESLA | 2.788 |
| RHEINMETALL | 1.588 |
| RENK GROUP | 1.393 |
| TUI | 1.371 |
| BYD | 1.339 |
| THYSSENKRUPP | 1.244 |
| STEYR MOTORS | 1.217 |
| APPLE | 1.196 |
| PUMA | 1.194 |
| DEUTZ | 1.161 |
| AMAZON | 1.137 |
| NEL | 1.136 |
| VOLKSWAGEN | 1.033 |
| BASF | 982 |
| MERCEDES-BENZ | 882 |
| NIKE | 825 |
| EVOTEC | 788 |
| BAYER | 775 |
| AIXTRON SE | 683 |
| NOVO NORDISK | 683 |
| DEUTSCHE BANK | 677 |
| NORDEX | 672 |
| PORSCHE AG | 658 |
| XIAOMI | 642 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
